Fibroblast Growth Factor 23 (FGF23) Antibody

Este producto es parte de FGF23 - Fibroblast Growth Factor 23
Product Graph
52€ (10 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Fibroblast Growth Factor 23 (FGF23) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx014000
tested applications
ELISA, IF/ICC

Description

Rabbit polyclonal antibody against FGF23 protein. Immunogen region is Internal.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Fibroblast Growth Factor 23 (FGF23)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
ELISA: 1/20000, IF/ICC: 1/100 - 1/500. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
Size 1
10 µg
Size 2
100 µg
Size 3
200 µg
Size 4
300 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA, IF/ICC
Buffer
PBS (without Mg<sup>2+</sup> and Ca<sup>2+</sup>), pH 7.4, 150 mM NaCl, 0.02% sodium azide, 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q9GZV9, Q9EPC2, Q8VI82
Gene ID
8074, 64654, 170583
NCBI Accession
NP_065689.1, NP_073148.1
OMIM
605380
Alias
ADHR,FGFN,HYPF,HFTC2,HPDR2,PHPTC,Phosphatonin,Tumor-derived hypophosphatemia-inducing factor
Background
Antibody anti-FGF23
Status
RUO
Note
Concentration: 1 mg/ml - 

Descripción

FGF23 is a phosphaturic hormone primarily secreted by osteocytes and osteoblasts in bone tissue. It regulates phosphate homeostasis and vitamin D metabolism by reducing phosphate reabsorption in the kidneys and suppressing the synthesis of 1,25-dihydroxyvitamin D. FGF23 binds to its receptor in the presence of α-Klotho, promoting phosphate excretion to maintain serum phosphate levels. Elevated FGF23 levels are associated with chronic kidney disease (CKD), where impaired renal function leads to hyperphosphatemia and secondary hyperparathyroidism. Mutations in FGF23 can cause disorders like hypophosphatemic rickets and osteomalacia, characterized by bone mineralization defects. FGF23’s role in phosphate balance and bone health makes it a key target for managing CKD and related mineral metabolism disorders.

Related Products

ECA0125

Canine FGF23 (Fibroblast Growth Factor 23) ELISA Kit

Ver Producto
EH3058

Human FGF23 (Fibroblast Growth Factor 23) ELISA Kit

Ver Producto
EP0058

Porcine FGF23 (Fibroblast Growth Factor 23) ELISA Kit

Ver Producto